Schedule 13G ownership disclosure
C4 Therapeutics Inc
Security class unavailable · CUSIP: 12529R107
Event date: 2024-01-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-007490
- Form type
- SC 13G
- Filer
- Betta Investment (Hong Kong) Ltd.
- CIK
- CIK 1990727
- Filed
- Jan 12, 2024
- Reporting period
- Jan 04, 2024
- Description
- Schedule 13G beneficial ownership